Pharma-Bio Serv (OTCMKTS:PBSV) Announces Quarterly Earnings Results, Misses Expectations By $0.04 EPS

Pharma-Bio Serv (OTCMKTS:PBSV) released its quarterly earnings results on Monday. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.04), Yahoo Finance reports. The firm had revenue of $2.42 million for the quarter, compared to the consensus estimate of $3.50 million. Pharma-Bio Serv had a negative return on equity of 0.04% and a negative net margin of 0.05%.

Pharma-Bio Serv Stock Performance

PBSV opened at $0.63 on Wednesday. The company has a fifty day moving average of $0.62 and a 200-day moving average of $0.69. Pharma-Bio Serv has a twelve month low of $0.52 and a twelve month high of $1.09.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.